kristina [she/her]@hexbear.net to science@hexbear.netEnglish · edit-25 months agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comexternal-linkmessage-square7fedilinkarrow-up172arrow-down10cross-posted to: news@lemmy.worldmedicine@mander.xyzupliftingnews@lemmit.onlinelgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
arrow-up172arrow-down1external-linkGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.www.cnbc.comkristina [she/her]@hexbear.net to science@hexbear.netEnglish · edit-25 months agomessage-square7fedilinkcross-posted to: news@lemmy.worldmedicine@mander.xyzupliftingnews@lemmit.onlinelgbtq_plus@lemmy.blahaj.zonehealth@lemmy.worldnews@lemmy.world
minus-squaregit [he/him, comrade/them]@hexbear.netlinkfedilinkEnglisharrow-up5·5 months agoCountries outside of the western pharmaceutical patent treaties will produce generics in due time.
Countries outside of the western pharmaceutical patent treaties will produce generics in due time.